Skip to content
★ Sign in to follow
KL

Kimble L. Jenkins

Executive
Total declarations
21
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 01 Oct 2020 for ClearPoint Neuro, Inc., €2,664.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Kimble L. Jenkins: trading record in brief

All filings by Kimble L. Jenkins on record concern ClearPoint Neuro, Inc. We count 21 filings; the first trade dates from 30 June 2015 and the latest from 30 September 2020.

No open-market sale appears; the market trades are 1 purchase. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 20 share grants.

The latest filing, published on 1 October 2020, reports a share grant of €2,664 in ClearPoint Neuro, Inc. The last purchase on record was published on 30 May 2017, which is 3,450 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Kimble L. Jenkins

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations